​A re-analysis of time to onset (TTO) from a previously published study by Boyle et al, using the Airsonett Air4 Temperature-controlled Laminar Airflow technology (TLA), by Professor Leif Bjermer, concludes that Nocturnal treatment with TLA provided a statistically significant and clinically relevant improvement in Quality of Life (AQLQ) within 3 months in patients with poorly controlled asthma.
Download in PDF-format.